<DOC>
	<DOCNO>NCT00091793</DOCNO>
	<brief_summary>This study determine whether treatment AMG 162 prevent lumbar spine bone loss early late postmenopausal woman osteopenia , test safety tolerability AMG 162 population .</brief_summary>
	<brief_title>Study Evaluate AMG 162 Prevention Postmenopausal Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Denosumab</mesh_term>
	<criteria>Eligibility Criteria Postmenopausal woman Osteopenia ( lumbar spine bone mineral density Tscore 1.0 2.5 )</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>Postmenopausal</keyword>
</DOC>